Atlas Trials

Prospective Study on the Efficacy and Safety of Bronchoalveolar Lavage Combined With Pathogen Metagenomic Sequencing Technology in the Diagnosis of Immune Checkpoint Inhibitor Associated Pneumonia

Clinical trial NCT06192303 · UNKNOWN

Trial details

NCT number
NCT06192303
Sponsor
Nanfang Hospital, Southern Medical University
Status
UNKNOWN
Study type
OBSERVATIONAL
Immune Checkpoint Inhibitor Associated Pneumonia
Start date
2023-01-01
Primary completion
2025-05-01
Enrollment
104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.